Trial Profile

A Randomized, Vehicle-Controlled, Parallel Group Study of Topical TDM-180935 to Evaluate the Preliminary Efficacy, Safety, Tolerability, and Pharmacokinetics in Atopic Dermatitis Patients

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs TDM-Atop01 (Primary)
Indications Atopic dermatitis
Focus Proof of concept; Therapeutic Use
Sponsors TechnoDerma Medicines

Most Recent Events

08 Jan 2025 Results presented in media release.
06 Jan 2025 Results published in the Technoderma Medicines media release
06 Jan 2025 According to Technoderma Medicines media release, Primary endpoint (Change in m-EASI (modified Eczema Area and Severity Index) score) has been met.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com